Received Nov 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | LM2215 | LA |
Grand mal seizure; This is a spontaneous report received from a Consumer or other non HCP and an Other HCP. A 68-year-old male patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), on 06Sep2024 as dose 1, 0.3 ml single (Lot number: LM2215) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "epileptic" (ongoing); "heart stent", start date: 2021 (unspecified if ongoing); "stage 4 lymphoma" (unspecified if ongoing); "kidney transplant" (unspecified if ongoing). The patient took concomitant medications. Vaccination history included: Flu shot (DOSE NUMBER UNKNOWN), for Immunization; Rsv shot (DOSE NUMBER UNKNOWN), for Immunization; Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Booster), for COVID-19 immunization. The following information was reported: GENERALISED TONIC-CLONIC SEIZURE (hospitalization) with onset 07Sep2024, outcome "unknown", described as "Grand mal seizure". The clinical course was reported as follows: The patient reported that he had been epileptic for 45 years or a long time. He had kidney transplant and received a kidney about 15 or 16 years ago, had stage 4 lymphoma roughly 7 or 8 years ago and he received the vaccine since it came out for the last roughly 5 or 6 years and has been receiving it. On Sep2024 after he received the covid 19 vaccine, the next morning he had a grand mal seizure, he was a very controlled epileptic. He ended up admitted to the hospital for 4 or 5 days since it was a pretty serious two grand mal seizures in a row, one at home and another one once admitted in the hospital. He was discharged from hospital in Sep2024. The patient received extra doses of phenytoin (DILANTIN). The patient also reported he was on blood thinners and on anti-rejection drugs for his kidney transplant. After the event occurrence he consulted with his kidney transplant doctor and with his primary doctor. The patient was hospitalized for generalised tonic-clonic seizure (start date: Sep2024, discharge date: Sep2024). The patient underwent the following laboratory tests and procedures: Body height: little over 5'11'', notes: close to 6 feet; Weight: 200 to 202. Therapeutic measures were taken as a result of generalised tonic-clonic seizure.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202500221913 Same patient and product, different dose;
Epilepsy
Medical History/Concurrent Conditions: Cardiac stent placement; Kidney transplant; Lymphoma
Test Name: Height; Result Unstructured Data: Test Result: little over 5'11''; Comments: close to 6 feet; Test Name: Weight; Result Unstructured Data: Test Result: 200 to 202 lbs